-
1
A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology
Published 2022-01-01Subjects: Get full text
Article -
2
Synergistic Interactions between the Hypomethylating Agent Thio-Deoxycytidine and Venetoclax in Myelodysplastic Syndrome Cells
Published 2023-02-01Subjects: Get full text
Article -
3
Apatinib enhances chemosensitivity of ABT‐199 in diffuse large B‐cell lymphoma
Published 2022-10-01Subjects: “…ABT‐199…”
Get full text
Article -
4
Therapeutic Effects of the Bcl-2 Inhibitor on Bleomycin-induced Pulmonary Fibrosis in Mice
Published 2021-10-01Subjects: Get full text
Article -
5
MiRNA-16-1 Suppresses Mcl-1 and Bcl-2 and Sensitizes Chronic Lymphocytic Leukemia Cells to BH3 Mimetic ABT-199
Published 2022-08-01Subjects: “…abt-199…”
Get full text
Article -
6
Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug–Drug Interactions
Published 2016-02-01Subjects: “…ABT-199…”
Get full text
Article -
7
MDM2 inhibitor APG-115 synergizes with ABT-199 to induce cell apoptosis in chronic lymphocytic leukemia
Published 2024-07-01Subjects: Get full text
Article -
8
In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia
Published 2021-07-01Subjects: Get full text
Article -
9
Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms
Published 2022-11-01Subjects: Get full text
Article -
10
-
11
The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia
Published 2021-07-01Subjects: “…ABT-199…”
Get full text
Article -
12
Leishmania donovani induced increase in macrophage Bcl-2 favors parasite survival
Published 2016-10-01Subjects: Get full text
Article -
13
Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity
Published 2020-02-01Subjects: Get full text
Article -
14
Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence
Published 2022-10-01Subjects: Get full text
Article -
15
-
16
Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1
Published 2022-01-01Subjects: Get full text
Article -
17
Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199
Published 2021-04-01Subjects: “…ABT199…”
Get full text
Article -
18
Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells
Published 2020-12-01Subjects: Get full text
Article -
19
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
Published 2022-01-01Subjects: Get full text
Article -
20
Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell lines
Published 2020-07-01Subjects: Get full text
Article